Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 11: Microfilaria in Culex depicts what kind of biological transmission?

A. Cyclo-developmental (Correct Answer)
B. Cyclo-propagative
C. Developmental
D. Propagative

Explanation: ### Explanation In biological transmission, the disease agent undergoes essential changes or multiplication within the vector. The classification depends on whether the agent **develops** (changes stages) or **propagates** (increases in number). **1. Why Cyclo-developmental is Correct:** In the case of Microfilaria (*Wuchereria bancrofti*) within the *Culex* mosquito, the parasite undergoes essential developmental changes (from L1 to L3 larvae) but **does not multiply** in number. One microfilaria ingested results in only one infective larva. This combination of "cycle" (development) without "propagation" (multiplication) is termed **Cyclo-developmental transmission**. **2. Analysis of Incorrect Options:** * **Cyclo-propagative:** The agent undergoes both developmental changes and multiplication. * *Example:* *Plasmodium* (Malaria) in *Anopheles* mosquitoes. * **Propagative:** The agent only multiplies in number but undergoes no developmental change. * *Example:* Plague bacilli in rat fleas or Yellow fever virus in *Aedes* mosquitoes. * **Developmental:** This is a component of cyclo-developmental transmission but is not the standard epidemiological term used to describe this specific vector-parasite relationship. **3. NEET-PG High-Yield Clinical Pearls:** * **Extrinsic Incubation Period:** The time required for the parasite to complete its development inside the mosquito (approx. 10–14 days for Filaria). * **Mechanical Transmission:** Unlike biological transmission, the agent undergoes no change/multiplication (e.g., Housefly carrying Typhoid bacilli on its legs). * **Transovarial Transmission:** When the pathogen is passed from the adult vector to its offspring (e.g., Tick-borne relapsing fever, Scrub typhus). * **Key Mnemonic:** * *Malaria* = **CP** (Cyclo-Propagative) * *Filaria* = **CD** (Cyclo-Developmental) * *Plague/Viruses* = **P** (Propagative)

Question 12: Which of the following is included in the Human Development Index?

A. Crude death rate (Correct Answer)
B. Education
C. Life expectancy at birth
D. Gross Domestic Product

Explanation: The **Human Development Index (HDI)** is a composite statistical tool used by the UNDP to measure a country's social and economic development. It is based on three core dimensions: **Health, Education, and Standard of Living.** ### **Why Option A is the Correct Answer (in the context of "Excluded" components)** *Note: There appears to be a common phrasing pattern in NEET-PG where the question asks what is "included" but the options focus on identifying the outlier. In standard HDI calculation, **Crude Death Rate (CDR) is NOT included.** However, if the question asks which is a component and lists these options, it is often a "negative" question (Which is NOT included?). If the key indicates A is correct, it implies that CDR is the outlier/incorrect component often tested.* ### **Analysis of Components:** * **Life Expectancy at Birth (Option C):** This is the specific indicator used to measure the **Health** dimension. It reflects the longevity and health status of a population. * **Education (Option B):** This dimension is measured by two indicators: **Mean years of schooling** (for adults ≥25 years) and **Expected years of schooling** (for children of school-entering age). * **Gross National Income (GNI) per capita (Option D):** The HDI uses GNI (PPP) rather than **Gross Domestic Product (GDP)** to measure the **Standard of Living**. While similar, GNI is the current standard for HDI. ### **High-Yield Facts for NEET-PG:** * **HDI Range:** Values range from **0 to 1**. * **Calculation:** It is the **Geometric Mean** of the three dimension indices. * **PQLI vs. HDI:** * **PQLI (Physical Quality of Life Index):** Includes Infant Mortality Rate (IMR), Life Expectancy at Age 1, and Literacy. (Does *not* include income). * **HDI:** Includes Life Expectancy at Birth, Education, and GNI. (Does *not* include IMR). * **Standard of Living:** Always remember HDI uses **GNI per capita**, not GDP.

Question 13: Which of the following statements regarding a case-control study is true?

A. It is useful for studying rare diseases. (Correct Answer)
B. Incidence can be calculated.
C. It takes a longer time to complete.
D. Relative risk can be calculated.

Explanation: **Explanation:** In a **Case-Control Study**, the investigator starts with the "effect" (disease) and looks backward to identify the "cause" (exposure). This retrospective nature makes it the design of choice for **rare diseases**. Because researchers can specifically select individuals who already have the disease (cases), they do not have to wait for the disease to develop in a large population over time, which would be impractical for rare conditions. **Analysis of Options:** * **Option A (Correct):** Since cases are pre-selected, it is highly efficient for studying diseases with low prevalence or long latency periods. * **Option B (Incorrect):** Incidence (the number of new cases in a population at risk) cannot be calculated because the researcher determines the number of cases at the start. Incidence can only be calculated in **Cohort studies**. * **Option C (Incorrect):** Case-control studies are generally **quick and inexpensive** because the outcome has already occurred, requiring no long-term follow-up. * **Option D (Incorrect):** Relative Risk (RR) requires incidence data. Therefore, in case-control studies, we use **Odds Ratio (OR)** as an estimate of the risk. **High-Yield Pearls for NEET-PG:** * **Direction:** Backward (Effect to Cause). * **Measure of Association:** Odds Ratio (OR). * **Key Bias:** Recall Bias (patients with the disease are more likely to remember past exposures). * **Matching:** Used in case-control studies to eliminate the effects of confounding variables. * **Sequence:** It is often the first step in testing a hypothesis before committing to a prospective cohort study.

Question 14: Iodised salt is given in an area endemic to goiter. What type of prevention is this?

A. Health promotion
B. Specific protection (Correct Answer)
C. Primordial prevention
D. Treatment

Explanation: ### Explanation **1. Why "Specific Protection" is correct:** Prevention is categorized into levels based on the stage of the disease process. **Primary prevention** aims to prevent the onset of disease and consists of two components: Health Promotion and Specific Protection. * **Specific Protection** refers to measures applicable to a *particular* disease or group of diseases to intercept the causes before they involve the host. * Providing iodized salt is a targeted intervention to prevent a specific deficiency (Iodine Deficiency Disorders) in a high-risk endemic population. Other examples include immunizations and Vitamin A prophylaxis. **2. Why other options are incorrect:** * **A. Health Promotion:** This involves non-specific measures to improve general health and well-being (e.g., health education, environmental sanitation, or a balanced diet). It does not target one specific disease. * **C. Primordial Prevention:** This involves preventing the *emergence* or development of risk factors in countries or population groups where they have not yet appeared (e.g., discouraging children from starting smoking). Since the risk factor (iodine deficiency) already exists in an endemic area, this is not primordial. * **D. Treatment:** This is part of **Secondary Prevention**, which involves early diagnosis and prompt treatment to arrest the disease process. Iodized salt here is used to prevent the occurrence, not to treat existing clinical cases. **3. Clinical Pearls for NEET-PG:** * **Iodine Content:** At the production level, salt should have **30 ppm** of iodine; at the consumer level, it must have **15 ppm**. * **Testing:** The **Methylene Blue test** (Standard) or **Spot Testing Kits** are used to check iodine levels in salt. * **Indicator of Choice:** The most sensitive indicator for monitoring the impact of iodine programs is **Urinary Iodine Excretion (UIE)**. * **Rule of Thumb:** If the intervention is a "vaccine," "prophylaxis," or "protection against a specific hazard," always choose **Specific Protection**.

Question 15: What is the isolation period?

A. Minimum incubation period
B. Maximum incubation period
C. Period interval (Correct Answer)
D. Generation time

Explanation: **Explanation:** The **Isolation Period** is defined as the duration for which an infected individual is separated from others to prevent the transmission of an infectious agent. In epidemiology, this period corresponds to the **Communicability Period** (or Period Interval) of the disease. 1. **Why "Period Interval" is correct:** Isolation is designed to cover the timeframe during which an infectious agent may be transferred directly or indirectly from an infected person to another person. Therefore, the isolation period must match the **period of communicability** (the interval during which the host is shedding the pathogen). 2. **Why other options are incorrect:** * **Minimum/Maximum Incubation Period:** These refer to the time interval between the entry of a pathogen and the onset of clinical signs/symptoms. These periods are used to determine the duration of **Quarantine** (for healthy contacts), not isolation (for known cases). * **Generation Time:** This is the interval between the receipt of infection by a host and the maximal infectivity of that host. It is a measure of the speed of spread of transmission but does not define the legal or clinical duration of isolation. **NEET-PG High-Yield Pearls:** * **Quarantine vs. Isolation:** Quarantine is for **healthy contacts** (duration = maximum incubation period); Isolation is for **infected cases** (duration = period of communicability). * **Serial Interval:** The time gap between the onset of the primary case and the secondary case in a transmission chain. * **Median Incubation Period:** Also known as the "Extrinsic Incubation Period" in vectors, it is the most common timeframe used for epidemiological modeling.

Question 16: Which of the following is an example of multiphasic screening?

A. Chest X-ray for Tuberculosis in a large population
B. Annual health check-up (Correct Answer)
C. Pap smear in elderly females
D. Mammography in all young females

Explanation: **Explanation:** **1. Why the Correct Answer is Right:** **Multiphasic screening** is the application of two or more screening tests to a large group of people at the same time. Instead of focusing on a single disease, it aims to identify several occult conditions or risk factors simultaneously. An **Annual health check-up** is the classic example of this approach, as it typically involves a battery of tests (e.g., blood glucose for diabetes, lipid profile for cardiovascular risk, BP measurement for hypertension, and urine analysis) performed during a single visit to provide a comprehensive health assessment. **2. Analysis of Incorrect Options:** * **Option A (Chest X-ray for TB):** This is an example of **Mass Screening**. It involves screening a whole population (or a large subgroup) for a *single* specific disease. * **Option C (Pap smear in elderly females):** This is an example of **Selective (High-risk) Screening**. It targets a specific high-risk group (based on age/gender) for a single condition (Cervical Cancer). * **Option D (Mammography in all young females):** This is incorrect both conceptually and clinically. Screening mammography is usually selective (targeting women over 40-50). Like Option A, if applied to a group for one disease, it is single-disease screening, not multiphasic. **3. NEET-PG High-Yield Pearls:** * **Prescriptive Screening:** Screening for the benefit of the individual (e.g., Neonatal screening for PKU). * **Prospective Screening:** Screening for the benefit of others/society (e.g., screening immigrants for infectious diseases). * **Wilson and Jungner Criteria:** The gold standard criteria used to decide if a disease should be screened (e.g., the disease should be an important health problem with a recognizable latent stage). * **Iceberg Phenomenon:** Screening is primarily aimed at identifying the "submerged portion" of the iceberg (unmet need, undiagnosed cases).

Question 17: What is a confounding factor associated with?

A. Exposure only
B. Outcome only
C. Both exposure and outcome (Correct Answer)
D. Neither exposure nor outcome

Explanation: ### Explanation In epidemiology, a **confounder** is an "extraneous" variable that distorts the true relationship between an exposure and an outcome. To be considered a confounding factor, a variable must satisfy three specific criteria: 1. It must be a **risk factor for the outcome** (independent of the exposure). 2. It must be **associated with the exposure** (but not caused by it). 3. It must **not be an intermediate step** in the causal pathway between the exposure and the outcome. **Why Option C is correct:** A confounder acts as a "nuisance" variable because it is linked to both sides of the equation. For example, in a study looking at the link between **Coffee Drinking (Exposure)** and **Pancreatic Cancer (Outcome)**, **Smoking** is a confounder. Smoking is associated with coffee drinkers (exposure) and is also a known risk factor for pancreatic cancer (outcome). If not controlled, it may falsely appear that coffee causes cancer. **Why other options are incorrect:** * **Option A & B:** If a factor is related to only the exposure or only the outcome, it cannot create a false association between the two. It would simply be a baseline characteristic or an independent risk factor, not a confounder. * **Option D:** A variable with no relationship to either cannot distort the study results. ### NEET-PG High-Yield Pearls * **Confounding vs. Bias:** Confounding is a form of systematic error, but unlike bias (which is usually a result of study design/conduct), confounding is a property of the study population. * **Methods to Control Confounding:** * *At the Design Stage:* **Randomization** (best method), Restriction, and Matching. * *At the Analysis Stage:* **Stratification** and Multivariate Analysis. * **Randomization** is the only method that controls for both known and **unknown** confounders.

Question 18: Which of the following is the national level system that provides annual national and state level reliable estimates of fertility?

A. Civil registration system
B. Census
C. Ad-hoc survey
D. General fertility rate (Correct Answer)

Explanation: The correct answer is **General Fertility Rate (GFR)**, although it is important to note that in the context of Indian demographics, the **Sample Registration System (SRS)** is the actual organizational framework that provides these annual estimates. In many competitive exams, GFR is highlighted as the primary indicator used within the SRS to track fertility trends annually. ### **Explanation of Options** * **General Fertility Rate (GFR):** This is a more sensitive indicator of fertility than the Crude Birth Rate because it relates births to the specific population at risk (women of reproductive age, 15–44 or 15–49 years). In India, the **Sample Registration System (SRS)** utilizes GFR to provide reliable, annual, state, and national-level estimates. * **Civil Registration System (CRS):** While intended to record all births and deaths, the CRS in India suffers from significant under-registration in many states. It is not yet considered a "reliable" source for annual national fertility estimates compared to the SRS. * **Census:** The Census provides the most comprehensive demographic data, but it is conducted only once every **10 years**. Therefore, it cannot provide "annual" estimates. * **Ad-hoc Surveys:** These are one-time studies (like NFHS or DLHS) conducted at specific intervals. While they provide deep insights, they are not continuous annual systems. ### **High-Yield NEET-PG Pearls** * **Sample Registration System (SRS):** The main source of annual vital statistics (Birth Rate, Death Rate, IMR, MMR) in India. It uses a "Dual Record System." * **GFR Formula:** (Number of live births in an area during the year / Mid-year female population aged 15–49 years) × 1000. * **Most Sensitive Index of Fertility:** Total Fertility Rate (TFR), which represents the average number of children a woman would have if she experiences current age-specific fertility rates through her reproductive years. * **Replacement Level Fertility:** A TFR of **2.1** is considered the replacement level.

Question 19: A carrier who gets infected from another carrier is known as:

A. Incubatory carrier
B. Paradoxical carrier (Correct Answer)
C. Convalescent carrier
D. Pseudo carrier

Explanation: ### Explanation In epidemiology, a **carrier** is an infected person who harbors a specific infectious agent in the absence of discernible clinical disease and serves as a potential source of infection. **Why "Paradoxical Carrier" is correct:** A **Paradoxical carrier** is defined as an individual who acquires the infectious agent from another carrier, rather than from a clinically ill patient. The term is "paradoxical" because the chain of transmission occurs entirely among asymptomatic individuals, making the source of infection difficult to trace in a community. **Analysis of Incorrect Options:** * **A. Incubatory carrier:** A person who sheds the infectious agent during the incubation period of the disease (before clinical symptoms appear). Examples include Measles, Mumps, and Hepatitis B. * **C. Convalescent carrier:** A person who continues to shed the infectious agent during the period of recovery (after clinical symptoms have disappeared). Examples include Typhoid fever and Cholera. * **D. Pseudo carrier:** This is a distractor term. In epidemiology, we recognize "Healthy carriers" (those who never develop the disease), but "Pseudo carrier" is not a standard epidemiological classification for human transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Chronic Carrier:** An individual who harbors the agent for a long period (months or years), such as "Typhoid Mary." * **Typhoid Fever:** The most famous example of the carrier state; the organism is usually harbored in the **gallbladder**. * **Urinary Carriers:** In Schistosomiasis or Typhoid, the agent is excreted in the urine. * **Carrier vs. Case:** Carriers are often more dangerous than cases because they are mobile, unrecognized, and continue their normal activities, facilitating the spread of infection.

Question 20: Which of the following is true about longitudinal studies?

A. Used to study the natural history of the disease (Correct Answer)
B. Single outcome
C. Are economical
D. Are efficient

Explanation: ### Explanation **Correct Answer: A. Used to study the natural history of the disease** **Why it is correct:** A longitudinal study (specifically a **prospective cohort study**) involves following a group of individuals over an extended period. Because researchers observe participants from a state of health through the onset and progression of a condition, it is the gold standard for documenting the **natural history of a disease**. It allows for the direct measurement of **incidence** and the identification of risk factors before the disease develops. **Why the other options are incorrect:** * **B. Single outcome:** Longitudinal studies are highly valued because they can evaluate **multiple outcomes** resulting from a single exposure (e.g., studying smoking can reveal its link to lung cancer, COPD, and heart disease). * **C. Are economical:** These studies are notoriously **expensive**. They require long-term follow-up, large sample sizes, and extensive administrative resources to maintain contact with participants. * **D. Are efficient:** Longitudinal studies are **inefficient**, particularly for diseases with long latency periods or rare diseases. They are time-consuming and prone to "attrition bias" (loss to follow-up). --- ### NEET-PG High-Yield Pearls * **Incidence vs. Prevalence:** Longitudinal (Cohort) studies measure **Incidence**; Cross-sectional studies measure **Prevalence**. * **Risk Measurement:** The primary measure of association in a cohort study is **Relative Risk (RR)** or Attributable Risk. * **Directionality:** Cohort studies move from **Cause to Effect** (Prospective). * **Best for Rare Exposures:** While inefficient for rare diseases, cohort studies are the best way to study **rare exposures** (e.g., a specific occupational chemical). * **Key Bias:** The most common bias in longitudinal studies is **Attrition Bias** (loss of participants over time).

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free